Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Rheumatology|January 27, 2004
Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infectionP Lamprecht, O Gutzeit, E Csernok, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's diseaseJ Damoiseaux, M Vaessen, Y Knapen, et al.
Clinical and Experimental Immunology|September 1, 2001
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitisE Peen, C Malone, C Myers, et al.
Journal of Immunological Methods|September 20, 1991
A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosisW J Mayet, E Hermann, E Csernok, et al.
The Journal of Pathology|August 22, 2000
Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expressionA Müller, A Trabandt, K Gloeckner-Hofmann, et al.
Clinical and Experimental Rheumatology|January 27, 2004
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associationsH Schultz, E Csernok, K Herlyn, et al.
Infection|April 29, 1999
Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infectionO A Cornely, S Hauschild, C Weise, et al.
Annals of the Rheumatic Diseases|July 19, 2011
Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's)F O Henes, Y Chen, T A Bley, et al.
Hematological Oncology|June 1, 1996
Monoclonal antibody WGM1 directed against proteinase 3: an immunohistochemical marker for naphthol ASD chloroacetateM G Braun, E Csernok, W Rögener-Schwarz, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS)P Lamprecht, F Moosig, S Adam-Klages, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Rheumatology|January 27, 2004
Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infectionP Lamprecht, O Gutzeit, E Csernok, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's diseaseJ Damoiseaux, M Vaessen, Y Knapen, et al.
Clinical and Experimental Immunology|September 1, 2001
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitisE Peen, C Malone, C Myers, et al.
Journal of Immunological Methods|September 20, 1991
A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosisW J Mayet, E Hermann, E Csernok, et al.
The Journal of Pathology|August 22, 2000
Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expressionA Müller, A Trabandt, K Gloeckner-Hofmann, et al.
Clinical and Experimental Rheumatology|January 27, 2004
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associationsH Schultz, E Csernok, K Herlyn, et al.
Infection|April 29, 1999
Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infectionO A Cornely, S Hauschild, C Weise, et al.
Annals of the Rheumatic Diseases|July 19, 2011
Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's)F O Henes, Y Chen, T A Bley, et al.
Hematological Oncology|June 1, 1996
Monoclonal antibody WGM1 directed against proteinase 3: an immunohistochemical marker for naphthol ASD chloroacetateM G Braun, E Csernok, W Rögener-Schwarz, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS)P Lamprecht, F Moosig, S Adam-Klages, et al.
Pageof 11